News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
793,629 Results
Type
Article (80149)
Company Profile (481)
Press Release (712999)
Multimedia
Podcasts (115)
Webinars (13)
Section
Business (211401)
Career Advice (3739)
Deals (37941)
Drug Delivery (126)
Drug Development (89760)
Employer Resources (183)
FDA (17769)
Job Trends (16436)
News (369001)
Policy (37060)
Tag
Academia (2988)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (53611)
ALS (101)
Alzheimer's disease (1502)
Antibody-drug conjugate (ADC) (160)
Approvals (17731)
Artificial intelligence (303)
Autoimmune disease (29)
Automation (16)
Bankruptcy (380)
Best Places to Work (12529)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (357)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (304)
Cancer (2449)
Cardiovascular disease (207)
Career advice (3181)
Career pathing (34)
CAR-T (175)
Cell therapy (491)
Cervical cancer (22)
Clinical research (72473)
Collaboration (920)
Company closure (1)
Compensation (570)
Complete response letters (30)
COVID-19 (2862)
CRISPR (49)
C-suite (270)
Cystic fibrosis (108)
Data (2300)
Decentralized trials (2)
Denatured (41)
Depression (56)
Diabetes (299)
Diagnostics (6829)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (137)
Drug pricing (128)
Drug shortages (33)
Duchenne muscular dystrophy (103)
Earnings (81997)
Editorial (45)
Employer branding (23)
Employer resources (158)
Events (124112)
Executive appointments (780)
FDA (19131)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (819)
Gene editing (123)
Generative AI (29)
Gene therapy (361)
GLP-1 (852)
Government (5101)
Grass and pollen (6)
Guidances (92)
Healthcare (20702)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (149)
Indications (30)
Infectious disease (3024)
Inflammatory bowel disease (157)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (102)
Interviews (731)
IPO (17451)
IRA (51)
Job creations (4374)
Job search strategy (2594)
Kidney cancer (11)
Labor market (37)
Layoffs (551)
Leadership (24)
Legal (8817)
Liver cancer (82)
Lung cancer (347)
Lymphoma (160)
Machine learning (7)
Management (63)
Manufacturing (346)
MASH (76)
Medical device (14400)
Medtech (14405)
Mergers & acquisitions (21064)
Metabolic disorders (791)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2112)
NextGen: Class of 2025 (7492)
Non-profit (5062)
Now hiring (39)
Obesity (426)
Opinion (275)
Ovarian cancer (79)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (161)
Partnered (22)
Patents (252)
Patient recruitment (117)
Peanut (51)
People (63097)
Pharmaceutical (95)
Pharmacy benefit managers (22)
Phase I (22409)
Phase II (31504)
Phase III (23694)
Pipeline (1305)
Policy (173)
Postmarket research (3390)
Preclinical (10087)
Press Release (71)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (431)
Real estate (6732)
Recruiting (72)
Regulatory (25473)
Reports (42)
Research institute (2644)
Resumes & cover letters (593)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (93)
Service/supplier (13)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (3946)
State (2)
Stomach cancer (16)
Supply chain (74)
Tariffs (48)
The Weekly (72)
Vaccines (809)
Venture capitalists (44)
Weight loss (301)
Women's health (39)
Worklife (20)
Date
Today (138)
Last 7 days (783)
Last 30 days (2931)
Last 365 days (34949)
2025 (11889)
2024 (37493)
2023 (42221)
2022 (53570)
2021 (58357)
2020 (57270)
2019 (50892)
2018 (38737)
2017 (36142)
2016 (36563)
2015 (42367)
2014 (36474)
2013 (32888)
2012 (34780)
2011 (34849)
2010 (34598)
Location
Africa (1154)
Alabama (59)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (46836)
Australia (8278)
California (6467)
Canada (2065)
China (568)
Colorado (280)
Connecticut (300)
Delaware (155)
Europe (108234)
Florida (944)
Georgia (213)
Idaho (63)
Illinois (625)
India (28)
Indiana (330)
Iowa (12)
Japan (172)
Kansas (108)
Kentucky (26)
Louisiana (13)
Maine (70)
Maryland (964)
Massachusetts (4939)
Michigan (242)
Minnesota (418)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (70)
New Jersey (1827)
New Mexico (31)
New York (1834)
North Carolina (1114)
North Dakota (9)
Northern California (2792)
Ohio (220)
Oklahoma (15)
Oregon (39)
Pennsylvania (1425)
Puerto Rico (13)
Rhode Island (33)
South America (1521)
South Carolina (24)
South Dakota (1)
Southern California (2413)
Tennessee (100)
Texas (956)
United States (24689)
Utah (194)
Virginia (162)
Washington D.C. (69)
Washington State (592)
West Virginia (3)
Wisconsin (68)
793,629 Results for "american association for the study of liver diseases".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
November 18, 2024
·
4 min read
Press Releases
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress
April 15, 2025
·
5 min read
Press Releases
Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the Liver (EASL) Congress 2025
April 23, 2025
·
4 min read
Press Releases
Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
October 15, 2024
·
2 min read
Press Releases
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
April 23, 2025
·
2 min read
Approvals
Mirum Establishes Liver Expertise With First FDA Nod for ‘Very Rare’ Disease
Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and upcoming drug volixibat.
February 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
May 5, 2025
·
12 min read
Biotech Beach
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
Gyre Therapeutics announced the presentation of a poster at the American Association for the Study of Liver Diseases’ Annual Liver Meeting, November 10-14, 2023, in Boston, Massachusetts.
November 13, 2023
·
5 min read
News
Gilead to Present Latest Research Across Key Liver Disease Indication at the American Association for the Study of Liver Disease (AASLD) Meeting 2024
October 22, 2024
·
16 min read
Press Releases
Vivet Therapeutics to Present Key Findings on its Gene Therapy Program for Cerebrotendinous Xanthomatosis at the American Association for the Study of Liver Diseases Annual Meeting
November 14, 2024
·
7 min read
1 of 79,363
Next
